Caprylic/Capric Triglyceride (and) Iron Oxides (CI 77491) (and) Iron Oxides (CI 77492) (and) Iron Oxides (CI 77499) (and) Polyhydroxystearic Acid
Iron Oxides Dispersion (skin-tone blend)
What it does
This ingredient serves a specialized role in cosmetic formulations, contributing to the overall efficacy, stability, or sensory experience of the final product.
- Enhances formula performance
- Contributes to product quality
- Supports formulation goals
- Improves user experience
Ingredient compatibility
Known Interactions
Calcium inhibits both heme and non-heme iron absorption by 50-60% when taken together. These minerals compete for the same absorption pathways. Separate by at least 2 hours or formulate for different serving times.
Iron and Zinc compete for the DMT1 transporter when taken as inorganic salts at high doses. At supplemental doses (>25mg each), absorption of both is reduced 30-50%. Use chelated forms or separate doses.
Iron + Tannins form dark-colored insoluble complexes (ink-like precipitate), common in tea/coffee + iron fortification. Use iron bisglycinate or EDTA-chelated iron to prevent.
Iron from iron oxide pigments can catalyze oxidation of Ascorbic Acid via Fenton reaction. Not a concern at typical pigment levels in tinted products, but avoid high concentrations of both.
EDTA chelates free iron strongly. Intentional in some applications (prevents oxidation catalysis) but can reduce iron bioavailability in supplements/beverages. Verify this is the intended behavior.